Posts Tagged Development
-
Evotec AG and 4-Antibody AG Form Strategic Collaboration to Innovate Antibody Selection
Evotec and 4-Antibody Launch New High Content Screening Platform for Early Antibody Functionality Testing Novel Screening Process Integrates 4-Antibody Discovery Platform and Offers Evotec Customers New Possibilities for Reduced Late Stage Attrition and Better Efficacy HAMBURG, Germany and ...
-
Oxygen Biotherapeutics Secures Long-Term Clinical Supply of Oxycyte(R)
MORRISVILLE, N.C., May 3, 2012 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT), a development stage biomedical company ("the Company") focused on developing perfluorocarbon-based intravenous and topical drug candidates, today announced it has achieved the critical milestone of securin...
-
New Drug Application for Arzerra Submitted in Japan
- New Drug Application for Arzerra submitted to Japanese regulatory authorities COPENHAGEN, Denmark, April 27, 2012 (GLOBE NEWSWIRE) -- GlaxoSmithKline (GSK) and Genmab A/S (Copenhagen:GEN) announced today the submission of a New Drug Application (NDA) to the Japanese Ministry of Health, Labor a...
-
Intellipharmaceutics Announces First Quarter 2012 Results
TORONTO, April 12, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the resul...
-
Gazit-Globe Reports Fourth Quarter and Year-End 2011 Financial Results
Total investments of NIS 9.6 billion during 2011 NOI & FFO grew by 15% and 13% respectively, Same Property NOI grew by 4.0% TEL-AVIV, Israel, March 28, 2012 (GLOBE NEWSWIRE) -- Gazit-Globe (TASE:GLOB), one of the world's leading multi-national real estate companies focused on acquisition, d...
-
Nidec Techno Motor Holdings to Construct R&D Center in Japan
KYOTO, Japan, March 25, 2012 (GLOBE NEWSWIRE) -- Nidec Corporation (NYSE:NJ) (the "Company") toady announced that one of its subsidiaries, Nidec Techno Motor Holdings Corporation ("NTMC"), will construct a research and development center named Fukui Technical Center in Fukui, Japan to bolster the de...
-
FHLB Dallas Appoints 2012 Advisory Council Members
DALLAS, March 22, 2012 (GLOBE NEWSWIRE) -- The Federal Home Loan Bank of Dallas (Bank) is pleased to announce the appointment of Jay Czar, Michelle Den Bleyker, Michael Gerber, Karen Phillips, and Michelle Whitten as new members of the Bank's 2012 Advisory Council (Council). Arlene Leviege, Nancy Ca...
-
U.S. Security Associates Receives Another Top Training Award
ATLANTA, March 20, 2012 (GLOBE NEWSWIRE) -- U.S. Security Associates Inc. (USA), a leading national provider of uniformed contract security services, had one of their employees recognized for a national award, Training magazine's Top Young Trainers. Jon Dimalanta, Vice President of Human Resources,...
-
Evotec FY 2011: Significant Growth and Focused Investments Drive Profitability and Innovation
HAMBURG, Germany, March 20, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today reported financial results and corporate updates for the year ended 31 December 2011. STRONG INCREASE IN 2011 REVENUES AND PROFITS; ALL FINANCIAL TARGETS MET OR EXCEEDED Revenue growth of +45% to â‚...
-
Synergy Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Financial
NEW YORK, March 15, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financial results for the fourth quarter and year ended December 31, 2011. Synergy is ...
-
Coronado Biosciences to Host Analyst & Investor Event in New York City
BURLINGTON, Mass., March 13, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc., (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, will be hosting an analyst and investor event on Friday, March 30...
-
Evotec Completes Squeeze-Out Process for DeveloGen
HAMBURG, Germany, Jan. 24, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced the completion of the squeeze-out process to acquire all of the remaining shares of DeveloGen AG from its minority shareholders. Evotec now is owner of 100% of the shares in DeveloGen. The former ...
-
ImmunoGen, Inc. Announces Antibody-Drug Conjugate Collaboration With Lilly
Agreement provides Lilly, a leader in the development of important cancer therapeutics, with access to ImmunoGen's TAP technology ImmunoGen to receive million upfront, milestone payments potentially totaling 0 million – for each target – and royalties on any commercial sales WALTHAM, ...
-
Chancery Court Denies SIGA’s Motion for Reconsideration in PharmAthene Litigation; Proceedings Continue
NEW YORK, Dec. 16, 2011 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight lethal disease-causing pathogens, announced today that the Delaware Chancery Court has denied its motion for reconsideration of certain aspec...
-
Immunomedics Announces Outcome of 2011 Annual Meeting of Stockholders
MORRIS PLAINS, N.J., Dec. 7, 2011 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that stockholder...
